Trial Profile
A Phase II study to evaluate the safety and histological response to Rituximab in adults with Sjogren's Syndrome
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 08 Dec 2011 New trial record